Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence, According to the Brazilian Public Health System Perspective.

The Brazilian public health system does not cover pharmacotherapy for urge urinary incontinence (UUI). The aim of this study was to estimate the cost-effectiveness and budget impact of providing tolterodine, solifenacin, oxybutynin (OXY), darifenacin, and mirabegron for the treatment of UUI in Brazilian public health system.

Significance of Overactive Bladder as a Predictor of Falls in Community-Dwelling Older Adults – One Year Follow-Up of the Sukagawa Study.

Little is known about the fall risk of older adults with overactive bladder, especially in the absence of urgency incontinence. We aimed to evaluate the impacts of overactive bladder with and without urgency incontinence (OAB-wet and OAB-dry) on the fall risk in older adults, and to investigate the importance of overactive bladder as a predictor […]

X